Concepedia

Randall J. Gallaschun

RJ

Statistics

Publications

10

Citations

757

H-Index

10

Active since

1989

Affiliations

Pfizer (United States)(Current)

Randall J. Gallaschun is an author at Pfizer (United States) specializing in medicinal chemistry, drug discovery, and medicine.

Top concepts

Publications per year

1989–2018

10

Publications

10

Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives

Rodney C. Schnur, Michael L. Corman, Randall J. Gallaschun et al. · Journal of Medicinal Chemistry · 1995 · 199 citations

erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships

Rodney C. Schnur, Michael L. Corman, Randall J. Gallaschun et al. · Journal of Medicinal Chemistry · 1995 · 138 citations

Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice

Stefan Just, Bertrand L. Chenard, Angelo Ceci et al. · PLoS ONE · 2018 · 135 citations · Full text

Synthesis and Oral Efficacy of a 4-(Butylethylamino)pyrrolo[2,3-<i>d</i>]pyrimidine:  A Centrally Active Corticotropin-Releasing Factor<sub>1</sub> Receptor Antagonist

Yuhpyng L. Chen, Robert S. Mansbach, Steven M. Winter et al. · Journal of Medicinal Chemistry · 1997 · 113 citations · Full text

, , +13

2-Aryloxy-4-alkylaminopyridines: Discovery of Novel Corticotropin-Releasing Factor 1 Antagonists

Yuhpyng L. Chen, R. Scott Obach, John P. Braselton et al. · Journal of Medicinal Chemistry · 2008 · 69 citations · Full text

1–5 of 10